- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT06056674
Enhetlig protokoll for forebygging av emosjonelle og akademiske utfordringer i utdanning (U-PEACE)
Enhetlig protokoll for å forhindre emosjonelle og akademiske utfordringer i utdanning (U-PEACE) randomisert kontrollert prøveversjon
The purpose of the study is to evaluate the feasibility and effectiveness of a program for high school students with emotional and academic challenges U-PEACE and gaining feedback on that program.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Florida
-
Coral Gables, Florida, Forente stater, 33146
- University of Miami
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
Youth:
-
Adolescents between the ages of 13 and 18 years at the time of enrollment, who:
- display depressive symptoms above the clinical cut-off of 9 or above on the Patient Health Questionnaire-8 (PHQ-8),
- display elevated anxiety symptoms of 10 or above on the Generalized Anxiety Disorder 7-item Scale (GAD-7; Spitzer et al., 2006),
- are enrolled at the target High Schools (HS),
- have expressed interest in participating in the study, and
- have a caregiver who is available to sign study consent forms (if under 18 years of age)
-
Adolescents must be, or are willing to be, consented to receive services through School Health Initiative (SHI) (i.e., SHI consent). If they are under 18 years of age, their caregiver must provide consent.
-
Adolescents and caregivers are able to complete all study procedures in English or Spanish.
Teachers:
- Individuals who are 18 years or older.
- Individuals who are currently employed at the target HSs.
- Individuals who are able to speak, read, and understand English.
Youth Exclusion Criteria:
-
The following individuals may be excluded at any time (e.g., before consent, after being enrolled).
- Individuals who do not wish to participate in this study and/or who are not able to read and understand the consent/assent.
- Individuals with self- or caregiver-reported history of seizures, neurological problems, autism spectrum disorder, substance use disorder, or serious mental illness (e.g., schizophrenia), and any indicator of a significant cognitive delay that would make U-PEACE inappropriate (e.g., full-time special education placement)
- Individuals with current anxiety or depressive symptoms or active suicidality at levels where more intensive services (e.g., day treatment, inpatient) would be warranted (e.g., hospitalization for suicidal behavior in the last 12 months).
-
Ineligible adolescents will be provided referrals to medical providers at the SHI, community agencies contracted with the Miami-Dade County Public Schools (M-DCPS) Office of Mental Health Services or emergency room settings, as appropriate.
-
Unclear cases will be reviewed by the PI and Director of the SHI, Co-I Lisa Gwynn, D.O.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: U-PEACE Group
Participants in this group will receive the U-PEACE intervention (study participation to last approximately 13 weeks). |
This program will involve about 13 group sessions, with each group session lasting approximately 40-50 minutes. The program session will be held about 2 times a week during the school day (e.g., lunch time) if the group meets in person, or at a pre-scheduled time every week if the group meets online via Zoom. Participants will learn how to better understand emotional experiences and use this understanding to embrace agency in challenging situations. Participants will develop skills to better deal with emotions by increasing awareness of what is happening in different settings and choose how to respond. Skill-building exercises may include mindfulness practices, flexible thinking, behavioral activation, problem-solving, and exposure activities. |
|
Aktiv komparator: Services As Usual (SAU) Group
Participants in this group will receive service as usual (study participation to last approximately 13 weeks). |
Participants in this group will continue to receive standard of care within their school clinic. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in Adolescent Academic Problems Checklist (AAPC)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
Scores on each item range from 0 to 3, with higher scores indicating more academic problems. |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
|
Therapeutic Alliance Scale for Children, Revised (TASC-R)
Tidsramme: Mid (approximately week 4)
|
Scores on each item range from 1 (not true) to 4 (very much true). This scale measures the perceived therapeutic alliance between child and therapist. |
Mid (approximately week 4)
|
|
Client Satisfaction Questionnaire (CSQ)
Tidsramme: Mid (approximately week 4)
|
Total Scores range from 8 to 32, with higher scores indicating greater client satisfaction. The CSQ support used to evaluate satisfaction with a particular intervention, client self-efficacy and the likelihood of recommending the intervention to others. |
Mid (approximately week 4)
|
|
Top Problems Assessment - Child Report as measured by Likert Scale
Tidsramme: Up to 13 weeks
|
The Top Problems assessment is used to identify self-reported target problems for treatment and track changes in problem severity over time. Identified top problem statements are rated on Likert scale from 0 (not at all a problem) to 10 (a huge problem). |
Up to 13 weeks
|
|
Adherence to U-PEACE, as Measured by Homework Completion
Tidsramme: At all group sessions (up to 9 weeks)
|
Adherence to U-PEACE will be measured by the overall number of homework assignments completed. |
At all group sessions (up to 9 weeks)
|
|
Adherence to U-PEACE, as Measured by Session Attendance
Tidsramme: At all group sessions (up to 9 weeks)
|
Adherence to U-PEACE will be measured by the overall number of sessions attended. |
At all group sessions (up to 9 weeks)
|
|
Change in Revised Children's Anxiety and Depression Scale - Child Revised Short Version (RCADS-C-S)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
The Change in Revised Children's Anxiety and Depression Scale - Child Revised Short Version (RCADS-25) is 25-item self-reported scale measuring symptoms of anxiety and depression in youth. Items are rated on a 4-point scale from 1 (Never) to 4 (always) with total composite scores ranging from 0 to 75. A score of 70 or higher indicates high severity. |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
|
Change in Generalized Anxiety Disorder 7-item Scale (GAD-7)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
GAD-7 evaluates core anxiety concerns across a 7-item self-report measure. Items are rated using a 4-point Likert scale from 0 (not at all) to 3 (nearly every day). It yields a total score and a rating of impairment |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
|
Change in Patient Health Questionnaire 9-item Scale (Modified for Major Depressive Disorder in Adolescents; PHQ-9M)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
PHQ-9 evaluates core depression symptoms across 9 items. Items are rated on a 4-point Likert scale from 0 (not at all) to 3 (nearly every day) |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
School Achievement, as measured by attendance
Tidsramme: Up to approximately 13 weeks
|
Attendance is defined as number of days attending school (not absent) |
Up to approximately 13 weeks
|
|
School Achievement, as measured by report card
Tidsramme: Up to approximately 13 weeks
|
School achievement will be measured by a numeric score on each participant's school report card |
Up to approximately 13 weeks
|
|
Change in Child Anxiety Impact Scale-Academic Subscale (CAIS-AS)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
CAIS-AS is a youth- and caregiver-report measure that assesses the impact of anxiety on function. The Academic sub scale assesses the impact of anxiety on assignments and tests, getting to school on time, etc. Items are rated on a 4-point Likert scale from 0 (not at all) to 3 (very much), with higher scores indicating greater impact of anxiety symptoms on academics |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
|
Change in Affective Reactivity Scale (ARI)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
ARI is a 7-item youth- and caregiver-report measure of irritability. Items are rated on a 3-point Likert scale from 0 (not true) to 2 (certainly true) |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
|
Change in Distress Tolerance Scale (DTS)
Tidsramme: At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
DTS is a 15-item youth report measure to evaluate emotional distress tolerance. Items are rated on a 5-point Likert scale from 1 (strongly agree) to 5 (strongly disagree) |
At baseline, mid (approximately week 4), post (approximately week 9) and 1-month follow-up (approximately week 13)
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Jill Ehrenreich-May, PhD, University of Miami
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 20230796
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .